Atlas Trials

Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Clinical trial NCT01735630 · COMPLETED

Trial details

NCT number
NCT01735630
Sponsor
OPKO Health, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2012-11-01
Primary completion
2015-05-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.